Dapagliflozin in Allo-HCT for aGVHD
Dapagliflozin in Allo-HCT for aGVHD
Recruiting · NCT06626737 · Registry updated 2025-06-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dapagliflozin in Allo-HCT for aGVHD | graft versus host disease, immune system disorder | Recruiting | Phase 2 | 2025-06-05 | NCT06626737 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The First Affiliated Hospital of Soochow University | 164 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of Soochow University | Suzhou | China | 36 |